Richard J Hawkins
CIK 1307632 · Chief Executive Officer · last filed 2026-05-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$924.7K
Companies
5
Total Filings
74
Lifetime Open-Market Net
-$1.05M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PSTV | Director | 15,188 | $5.01 | $76.1K | $25.5K | 12 | 2026-05-18 |
| SVRA | Director | 161,326 | $5.26 | $848.6K | -$205.6K | 14 | 2025-12-11 |
| LUMOS PHARMA, INC. (LUMO) Delisted | Chief Executive Officer | 0 | $4.34 | $0 | $39.3K | 12 | 2024-12-13 |
| PLUS THERAPEUTICS, INC. (CYTX) Delisted | Director | 8,435 | — | — | $0 | 15 | 2017-11-29 |
| SCICLONE PHARMACEUTICALS INC (SCLN) Delisted | Director | 0 | — | — | -$908.5K | 20 | 2017-10-16 |
Recent Filings · Page 4 of 8
74 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-02-03 | LUMOS PHARMA, INC. (LUMO) Delisted | Grant (A) | +2,329 | $0 | EDGAR |
| 2020-12-17 | SVRA | Grant (A) | — | $0 | EDGAR |
| 2020-06-29 | PSTV | Grant (A) | — | $0 | EDGAR |
| 2020-04-03 | LUMOS PHARMA, INC. (LUMO) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2019-12-26 | SVRA | Grant (A) | — | $0 | EDGAR |
| 2019-05-16 | SVRA | Mixed | — | -$264.6K | EDGAR |
| 2018-12-14 | SVRA | Grant (A) | — | $0 | EDGAR |
| 2018-07-27 | — | Exer (X) | — | $0 | |
| 2017-12-19 | SVRA | Grant (A) | — | $0 | EDGAR |
| 2017-11-29 | PLUS THERAPEUTICS, INC. (CYTX) Delisted | Exer (X) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.